RESMED INC (RMD)

US7611521078 - Common Stock

215.01  +1.02 (+0.48%)

Premarket: 215 -0.01 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
Revenue
4.58B4.22B3.58B3.20B2.96B
Cost Of Goods
2.03B1.87B1.55B1.35B1.24B
Gross Profit
2.56B2.36B2.02B1.84B1.72B
Operating Expenses
1.27B1.20B1.02B926.75M908.80M
Research and Development
304.81M287.64M253.57M225.28M201.90M
Selling, General, and Administrative Expenses
915.63M874.00M739.37M670.39M676.70M
Operating Income
1.29B1.15B1.00B917.58M809.00M
Interest Income/Expense
-49.83M-44.72M-43.00M-21.07M-63.10M
Other Income/Expense
-473.00K-5.71M3.20M1.05M1.00M
Non Recurring Items
N/A101.00K0.00-13.90M-13.90M
Income Before Taxes
1.18B1.10B960.48M883.66M733.10M
Income Tax
225.49M204.11M181.05M409.16M111.40M
Net Income
958.38M897.56M779.44M474.50M621.70M
EBITDA
1.47B1.32B1.16B1.07B963.90M
 
Per Share Data
EPS Diluted Total Ops
6.506.095.303.244.27
Non GAAP EPS
7.256.455.795.334.76
 
Statistics
Gross Profit Margin
55.78%55.78%56.57%57.69%58.09%
Profit Margin
20.91%21.25%21.78%14.84%21.02%
Operating Profit Margin
28.12%27.28%27.96%28.70%27.36%

All data in USD

Charts